Hint mode is switched on Switch off

Tango Therapeutics, ordinary share
TNGX, US87583X1090

Add a stock to WL
Choose all Reset all
Tango Therapeutics, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Tango Therapeutics Inc (formerly BCTG Acquisition Corp) is an operator of a biotechnology company intended to develop novel drugs for the treatment of cancer. The company leverages the genetic principle of synthetic lethality to discover and ...
Tango Therapeutics Inc (formerly BCTG Acquisition Corp) is an operator of a biotechnology company intended to develop novel drugs for the treatment of cancer. The company leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at driver genes in cancer that are focused on three core areas, including counteracting tumor suppressor gene loss, reversing the ability of cancer cells to evade the immune system and identifying novel combinations, enabling patients to get therapies that are more effective than single-agent therapy.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Tango Therapeutics Inc (formerly BCTG Acquisition Corp)
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    TNGX
  • Placement
    24.10.2025
  • Lock up period
    180
  • Number of papers
    21,023,337
  • Volume of raised funds
    182.06 mln USD
  • Placement share
    15.73%
  • Final placement price
    8.66 USD
  • Price change since placement date
    257.16%
  • By capitalization
    1,157.21 mln USD

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

08/06/2026 Tango Therapeutics (NASDAQ: TNGX) Stock Soars on Positive Pancreatic Cancer Trial Results and Upgrade
04/06/2026 Tango Therapeutics: Submission Of Matters To A Vote Of Security Holders
13/05/2026 Tango Therapeutics: Results Of Operations And Financial Condition, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
10/04/2026 Tango Therapeutics: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosures, Financial Statements And Exhibits
07/01/2026 Tango Therapeutics: Results Of Operations And Financial Condition, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosures, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.